Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lecaent 100mg capsules
0408010AEBDADAD
|
Lecaent | Pregabalin | Central Nervous System | 4 |
|
Lecaent 50mg capsules
0408010AEBDABAB
|
Lecaent | Pregabalin | Central Nervous System | 2 |
|
Lecaent 150mg capsules
0408010AEBDAEAE
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 200mg capsules
0408010AEBDAFAF
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 225mg capsules
0408010AEBDAGAI
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 25mg capsules
0408010AEBDAAAA
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 300mg capsules
0408010AEBDAHAG
|
Lecaent | Pregabalin | Central Nervous System | No data available |
|
Lecaent 75mg capsules
0408010AEBDACAC
|
Lecaent | Pregabalin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.